Daniele Pastori | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysis	INTERNAL AND EMERGENCY MEDICINE	2022
Sex-specific features of optical coherence tomography detected plaque vulnerability related to clinical outcomes: insights from the CLIMA study	THE INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING	2022
Performance of the HAS-BLED, ORBIT, and ATRIA bleeding risk scores on a cohort of 399 344 hospitalized patients with atrial fibrillation and cancer. data from the french national hospital discharge database	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2022
From the dining room to the atrium. can we modulate atrial fibrillation risk with micronutrients	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY	2022
Optical coherence tomography-derived lipid core burden index and clinical outcomes: results from the CLIMA registry	EUROPEAN HEART JOURNAL. CARDIOVASCULAR IMAGING	2022
Fibrosis-4 (FIB-4) Index and mortality in COVID-19 patients admitted to the emergency department	INTERNAL AND EMERGENCY MEDICINE	2022
Lipopolysaccharide induces platelet activation in HIV patients: the role of different viral load patterns	HIV MEDICINE	2021
Relation of Atrial Fibrillation to Angiographic Characteristics and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention	THE AMERICAN JOURNAL OF CARDIOLOGY	2021
Sex-related differences in the association between metabolic syndrome and gallstone disease	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH	2021
Identifying At-Risk Patients for Sustained Atrial High-Rate Episodes Using the C2HEST Score: The West Birmingham Atrial Fibrillation Project	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2021
Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study	CANCER	2021
Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study	INTERNAL AND EMERGENCY MEDICINE	2021
Sex-based difference in anticoagulated patients with mechanical prosthetic heart valves and long-term mortality risk	INTERNATIONAL JOURNAL OF CLINICAL PRACTICE	2021
Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a network metanalysis on 605,771 patients	EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY	2021
Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants	MAYO CLINIC PROCEEDINGS	2021
Nox2 up-regulation and hypoalbuminemia in patients with type 2 diabetes mellitus	FREE RADICAL BIOLOGY & MEDICINE	2021
Impact of the New Metabolic-Associated Fatty Liver Disease (MAFLD) on NAFLD Patients Classification in Italy	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY	2021
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)	BIOMEDICINES	2021
Assessment of hepatic fibrosis in MAFLD: A new player in the evaluation of residual cardiovascular risk?	DIGESTIVE AND LIVER DISEASE	2021
Statin use and mortality in atrial fibrillation: A systematic review and meta-analysis of 100,287 patients	PHARMACOLOGICAL RESEARCH	2021

ERC

LS4
LS4_10
LS7
LS7_10

Keywords

cardiovascular disease

anticoagulation

Novel oral anticoagulants

atrial fibrillation

atherosclerosis

NAFLD

NASH

antiphospholipid antibody syndrome

ischemic heart disease

cardiovascular risk

Thrombosis

Atherothrombosis

Progetti di Ricerca

Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.